Stock Earnings
Analysts review Nurix Therapeutics Inc’s rating
Nurix Therapeutics Inc’s recently made public that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0
Menu
Nurix Therapeutics Inc’s recently made public that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nurix Therapeutics
In a filing, Nurix Therapeutics Inc revealed its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Nurix Therapeutics Inc’s filing revealed that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nurix Therapeutics
In a filing, Nurix Therapeutics Inc revealed its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $68223.0